Metformin Improves Cardiac and Aortic Parameters in Adolescents with Type 1 Diabetes
In this medfyle
Expert commentary by Katherine A Sauder, PhD
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the ADA 2021 - 81st Scientific Sessions and presented by:
Alexander Nguyen, MD
University of Colorado
Denver, CO, USA
The content is produced by Infomedica, the official reporting partner of ADA 2021.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
Katherine A Sauder, PhD
University of Colorado Anschutz Medical Campus
Aurora, CO, USA
About the Expert
Katherine A Sauder, PhD
University of Colorado Anschutz Medical Campus
Aurora, CO, USA
Dr. Katherine Sauder is an Associate Professor of Pediatric Nutrition at the University of Colorado School of Medicine, and the Assistant Director for Translation Research at the Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center. Dr. Sauder’s research examines how nutrition and other health behaviors are related to obesity, diabetes, and cardiovascular disease risk in women and children. She uses both observational and intervention methods to identify and target health behaviors that can reduce risk for diabetes and obesity, with on-going projects spanning the transgenerational cycle. She has over 60 peer-reviewed publications, and her research has been continuously funded by the NIH since 2012.
Disclosures: Dr. Sauder's research program is supported by the National Institutes of Health.
References
1. Wiromrat P, Bjornstad P, Roncal C, et al. Serum uromodulin inversely associates with aortic stiffness in youth with type 1 diabetes: A brief report from EMERALD study. J Diabetes Complications 2019;33(6):434–6.
2. Schäfer M, Bjornstad P, Frank BS, et al. Frequency of Reduced Left Ventricular Contractile Efficiency and Discoordinated Myocardial Relaxation in Patients Aged 16 to 21 Years With Type 1 Diabetes Mellitus (from the Emerald Study). Am J Cardiol 2020;128:45–53.
3. Bjornstad P, Cree-Green M, Baumgartner A, et al. Achieving ADA/ISPAD clinical guideline goals is associated with higher insulin sensitivity and cardiopulmonary fitness in adolescents with type 1 diabetes: Results from RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) and Effects of MEtformin on CardiovasculaR Function in AdoLescents with Type 1 Diabetes (EMERALD) Studies. Pediatr Diabetes 2018;19(3):436-442.
